Journal of Clinical & Experimental Dermatology Research
Open Access
ISSN: 2155-9554
ISSN: 2155-9554
Ceilidh Stapelkamp
Novartis Pharmaceuticals UK Limited, Uxbridge, UB11 1BT, United Kingdom
Mayur M Amonkar, Ceilidh Stapelkamp, Suzanne Swann, and Michelle Casey were employees of GlaxoSmithKline during the time of study conduct and initial publication development
Dr. Ceilidh Stapelkamp is working in Novartis Pharmaceuticals UK . He is the Editorial Board Member of many peer reviewed journals and his area of expertise credits him with many publications in national and international journals. He is committed to highest standards of excellence and it proves through his/her authorship of many books.
Systematic review; Dabrafenib; Trametinib; First-line treatment; Metastatic melanoma; Indirect treatment comparisons; Dacarbazine